186 related articles for article (PubMed ID: 35324657)
1. Antinociceptive Actions of Botulinum Toxin A1 on Immunogenic Hypersensitivity in Temporomandibular Joint of Rats.
Muñoz-Lora VRM; Dugonjić Okroša A; Matak I; Del Bel Cury AA; Kalinichev M; Lacković Z
Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324657
[TBL] [Abstract][Full Text] [Related]
2. Modulatory effect of botulinum toxin type A on the microglial P2X7/CatS/FKN activated-pathway in antigen-induced arthritis of the temporomandibular joint of rats.
Manuel Muñoz-Lora VR; Abdalla HB; Del Bel Cury AA; Clemente-Napimoga JT
Toxicon; 2020 Nov; 187():116-121. PubMed ID: 32882256
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type a antinociceptive activity in trigeminal regions involves central transcytosis.
Nemanić D; Mustapić M; Matak I; Bach-Rojecky L
Eur J Pharmacol; 2024 Jan; 963():176279. PubMed ID: 38123005
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons.
Matak I; Rossetto O; Lacković Z
Pain; 2014 Aug; 155(8):1516-1526. PubMed ID: 24793910
[TBL] [Abstract][Full Text] [Related]
5. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice.
Matak I; Tékus V; Bölcskei K; Lacković Z; Helyes Z
Neuroscience; 2017 Sep; 358():137-145. PubMed ID: 28673722
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A reduces inflammatory hypernociception induced by arthritis in the temporomadibular joint of rats.
Lora VR; Clemente-Napimoga JT; Abdalla HB; Macedo CG; Canales GT; Barbosa CM
Toxicon; 2017 Apr; 129():52-57. PubMed ID: 28209481
[TBL] [Abstract][Full Text] [Related]
7. Bilateral analgesic effects of abobotulinumtoxinA (Dysport
Favre-Guilmard C; Chabrier PE; Kalinichev M
Eur J Pain; 2017 May; 21(5):927-937. PubMed ID: 28263010
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.
Cui M; Khanijou S; Rubino J; Aoki KR
Pain; 2004 Jan; 107(1-2):125-33. PubMed ID: 14715398
[TBL] [Abstract][Full Text] [Related]
9. Unilateral facial injection of Botulinum neurotoxin A attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice.
Chen WJ; Niu JQ; Chen YT; Deng WJ; Xu YY; Liu J; Luo WF; Liu T
J Headache Pain; 2021 May; 22(1):38. PubMed ID: 34000998
[TBL] [Abstract][Full Text] [Related]
10. Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.
Zychowska M; Rojewska E; Makuch W; Luvisetto S; Pavone F; Marinelli S; Przewlocka B; Mika J
Eur J Pharmacol; 2016 Nov; 791():377-388. PubMed ID: 27619001
[TBL] [Abstract][Full Text] [Related]
11. Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy.
Filipović B; Matak I; Bach-Rojecky L; Lacković Z
PLoS One; 2012; 7(1):e29803. PubMed ID: 22238656
[TBL] [Abstract][Full Text] [Related]
12. Botulinum Neurotoxin Chimeras Suppress Stimulation by Capsaicin of Rat Trigeminal Sensory Neurons In Vivo and In Vitro.
Antoniazzi C; Belinskaia M; Zurawski T; Kaza SK; Dolly JO; Lawrence GW
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202143
[TBL] [Abstract][Full Text] [Related]
13. Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and Akt.
Sikandar S; Gustavsson Y; Marino MJ; Dickenson AH; Yaksh TL; Sorkin LS; Ramachandran R
Eur J Neurosci; 2016 Jul; 44(1):1714-22. PubMed ID: 27108664
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin A, brain and pain.
Matak I; Lacković Z
Prog Neurobiol; 2014; 119-120():39-59. PubMed ID: 24915026
[TBL] [Abstract][Full Text] [Related]
15. The safety of botulinum neurotoxin type A's intraarticular application in experimental animals.
Okroša AD; Muñoz-Lora VRM; Matak I; Bach-Rojecky L; Kalinichev M; Lacković Z
Toxicon X; 2023 Jun; 18():100155. PubMed ID: 37096009
[TBL] [Abstract][Full Text] [Related]
16. Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.
Lacković Z; Filipović B; Matak I; Helyes Z
Br J Pharmacol; 2016 Jan; 173(2):279-91. PubMed ID: 26493010
[TBL] [Abstract][Full Text] [Related]
17. Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region.
Drinovac Vlah V; Filipović B; Bach-Rojecky L; Lacković Z
Eur J Pain; 2018 Mar; 22(3):583-591. PubMed ID: 29134730
[TBL] [Abstract][Full Text] [Related]
18. Spinal botulinum neurotoxin B: effects on afferent transmitter release and nociceptive processing.
Huang PP; Khan I; Suhail MS; Malkmus S; Yaksh TL
PLoS One; 2011 Apr; 6(4):e19126. PubMed ID: 21559464
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A.
Matak I; Bach-Rojecky L; Filipović B; Lacković Z
Neuroscience; 2011 Jul; 186():201-7. PubMed ID: 21539899
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Intra-Articular Injection of Botulinum Toxin Type A (IncobotulinumtoxinA) in Temporomandibular Joint Osteoarthritis: A Three-Arm Controlled Trial in Rats.
Béret M; Barry F; Garcia-Fernandez MJ; Chijcheapaza-Flores H; Blanchemain N; Chai F; Nicot R
Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
